Announcements

  • Topic Interpretation: Public Health

    2023-06-12

    What is Public Health?

    Public health is the science of protecting and improving the health of people and their communities. This work is achieved by promoting healthy lifestyles, researching disease and injury prevention, and detecting, preventing and responding to infectious diseases. Overall, public health is concerned with protecting the health of entire populations. These populations can be as small as a local neighborhood, or as big as an entire country or region of the world.

    Read more about Topic Interpretation: Public Health

  • Topic Interpretation: Pharmacoepidemiology

    2023-05-26

    What is Pharmacoepidemiology?

    Pharmacoepidemiology is the study of the use and effects of drugs in large numbers of people. It is a growing discipline that applies epidemiological techniques to study drug use in a large population. Just as the term implies, pharmacoepidemiology combines clinical pharmacology with epidemiology. Pharmacology is the study of the effects of medications in humans. It pertains to using pharmacokinetics and pharmacodynamics of a patient to predict the drug effect on a patient.

    Read more about Topic Interpretation: Pharmacoepidemiology

  • Topic Interpretation: Pharmacoeconomics

    2023-04-23

    What is Pharmacoeconomics?

    Pharmacoeconomics refers to the scientific discipline that compares the value of one drug or drug therapy to another. It is a sub-discipline of Health economics. Pharmacoeconomic study evaluates the cost (expressed in monetary terms) and effects (expressed in terms of monetary value, efficacy or enhanced quality of life) of a drug therapy to healthcare system and society.

    Read more about Topic Interpretation: Pharmacoeconomics

  • Call for papers

    2023-03-21

    We issue a call for papers in the hopes that exceptional peers will submit remarkable research and perspectives. We seek papers on a wide range of topics, as follows:

    Pharmacoeconomics

    (e.g., cancer-related, screening-related, and device-related economic evaluation)

    Evidence-based Medicine

    (e.g., effectiveness comparisons of drugs, real-world research)

    Health Measurement

    (e.g., patient-reported outcomes)

    Policy Reviews

    (e.g., China medical insurance and drug policy)

    Alternative Therapies

    (e.g., traditional Chinese medicine)

    Others related to health decision-making

    Read more about Call for papers

  • Health Decision is now indexed in J-Gate

    2023-02-17

    It is pleasure to announce that HD is now indexed in J-Gate. Please visit the following website to access J-Gate.

    https://jgateplus.com/

    About J-Gate: Launched in 2001 by Informatics India Limited, J-Gate is an electronic gateway to global e-journal literature. J-Gate provides seamless access to millions of journal articles. The J-Gate platform is fronted by a simple, intuitive, and easy-to-use interface, and also gives users complete control over search filters. By allowing users to access content from a wide variety of publishers on a single platform, J-Gate exponentially increases journal usage.

    Read more about Health Decision is now indexed in J-Gate

  • Health Decision: A new journal is launched

    2023-01-19

    Health Decision has been launched in January 2023.

    Aixia Ma, the Co-Editor-in-Chief, wrote the Inaugural Editorial of Health Decision. The topic of this article is “Improving evidence and outcomes in health decision-making in Asia-Pacific”. The editorial board was composed of young experts from the frontline of health science research and health decision-making from China, Singapore, the United States, and Europe. They drive the development of health decision-making in the Asia-Pacific region for the upcoming decades.

    Look forward to your attention!

    Read more about Health Decision: A new journal is launched